Zynteglo Suspension
Product Images NDC 73554-3111

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zynteglo (NDC 73554-3111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genetix Biotherapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Zynteglo 01)

Figure 1 (Zynteglo 01)
A line chart comparing HbAT87Q levels (g/dL) over months post drug product infusion for Study 1 and Study 2 subjects. The x-axis shows months from 0 to 48, while the y-axis shows HbAT87Q levels from 0 to 14 g/dL. Study data points include error bars and subject counts below the x-axis.*
FDA Label Image

Principal Display Panel (20 mL Bag Patient Identifier Label)

Principal Display Panel (20 mL Bag Patient Identifier Label)
Label for Zynteglo (betibeglogene autotemcel) suspension for intravenous infusion. The label states a 20 mL volume containing 2.0 to 20 million cells per mL, including CD34+ cells. It includes a section to confirm patient identifiers such as last name, first name, date of birth, patient ID, COI ID, lot number, expiry date, and other identifiers. The label also displays the Bluebird Bio logo and U.S. license number 2160.*
FDA Label Image

Principal Display Panel (20 mL Bag Label)

Principal Display Panel (20 mL Bag Label)
Label for Zynteglo (betibeglogene autotemcel) suspension for intravenous infusion by Genetix Biotherapeutics Inc. The label states a 20 mL suspension containing 2.0 to 20 million cells per mL, including 1.7 to 20 million CD34+ cells per mL. It includes usage instructions, warnings, and manufacturer information for bluebird bio, Inc., Somerville, MA. A barcode is also present.*
FDA Label Image

Principal Display Panel (20 mL Bag Cassette Label)

Principal Display Panel (20 mL Bag Cassette Label)
Label for Zynteglo (betibeglogene autotemcel) suspension for intravenous infusion, 20 mL containing 2.0 to 20 x 10^6 cells/mL. The label includes usage instructions for autologous use only, storage conditions, and manufacturer bluebird bio, Inc., Somerville, MA. It also features a barcode with NDC 73554-3111-1 and placeholders for patient identifiers and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.